Muscle diseases in the zebrafish

Neuromuscular Disorders

Volumn 22, Issue 8, 2012, Pages

  Lin, Yung Yao ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Danio rerio; Disease model; Muscle; Muscular dystrophy; Myopathy; Sarcomere; Zebrafish

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; 1,4 DIHYDROPYRIDINE RECEPTOR BETA1A; ACETYLCHOLINESTERASE; CHAPERONE; DYSTROGLYCAN; DYSTROPHIN; FUKUTIN; FUKUTIN RELATED PROTEIN; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 ALPHA1; INTEGRIN LINKED KINASE; LAMININ; LAMININ ALPHA2; LAMININ BETA2; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 1B; TROPONIN I; TROPONIN I2A.4; TROPONIN T; TROPONIN T2A; UNC45B PROTEIN; UNCLASSIFIED DRUG;

BECKER MUSCULAR DYSTROPHY; CENTRAL CORE DISEASE; DISEASE MODEL; DRUG RESEARCH; DUCHENNE MUSCULAR DYSTROPHY; FUNCTIONAL GENOMICS; GENE MUTATION; LIMB GIRDLE MUSCULAR DYSTROPHY; MAMMAL; MEDICAL RESEARCH; MULTIMINICORE DISEASE; MUSCULAR DYSTROPHY; NEUROMUSCULAR DISEASE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ZEBRA FISH;

EID: 84863863711     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.04.007     Document Type: Review

References (90)

1. Driever W., Stemple D., Schier A., Solnica-Krezel L. Zebrafish: genetic tools for studying vertebrate development. Trends Genet 1994, 10:152-159.
2. Amsterdam A., Burgess S., Golling G., et al. A large-scale insertional mutagenesis screen in zebrafish. Genes Dev 1999, 13:2713-2724.
3. Driever W., Solnica-Krezel L., Schier A.F., et al. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 1996, 123:37-46.
4. Haffter P., Granato M., Brand M., et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 1996, 123:1-36.
5. Granato M., van Eeden F.J., Schach U., et al. Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development 1996, 123:399-413.
6. Stickney H.L., Barresi M.J., Devoto S.H. Somite development in zebrafish. Dev Dyn 2000, 219:287-303.
7. Blagden C.S., Currie P.D., Ingham P.W., Hughes S.M. Notochord induction of zebrafish slow muscle mediated by Sonic hedgehog. Genes Dev 1997, 11:2163-2175.
8. Devoto S.H., Melancon E., Eisen J.S., Westerfield M. Identification of separate slow and fast muscle precursor cells in vivo, prior to somite formation. Development 1996, 122:3371-3380.
9. Henry C.A., Amacher S.L. Zebrafish slow muscle cell migration induces a wave of fast muscle morphogenesis. Dev Cell 2004, 7:917-923.
10. Davies K.E., Nowak K.J. Molecular mechanisms of muscular dystrophies: old and new players. Nat Rev Mol Cell Biol 2006, 7:762-773.
11. Godfrey C., Foley A.R., Clement E., Muntoni F. Dystroglycanopathies: coming into focus. Curr Opin Genet Dev 2011.
12. Ervasti J.M. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 2007, 1772:108-117.
13. Barresi R., Campbell K.P. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 2006, 119:199-207.
14. Mayer U. Integrins: redundant or important players in skeletal muscle?. J Biol Chem 2003, 278:14587-14590.
15. Kaplan J.C. The 2012 version of the gene table of monogenic neuromuscular disorders. Neuromuscul Disord 2011, 21:833-861.
16. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
17. Hoffman E.P., Fischbeck K.H., Brown R.H., et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 1988, 318:1363-1368.
18. Bell C.D., Conen P.E. Histopathological changes in Duchenne muscular dystrophy. J Neurol Sci 1968, 7:529-544.
19. Mandel J.L. Dystrophin. The gene and its product. Nature 1989, 339:584-586.
20. Stedman H.H., Sweeney H.L., Shrager J.B., et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991, 352:536-539.
21. Bassett D.I., Bryson-Richardson R.J., Daggett D.F., Gautier P., Keenan D.G., Currie P.D. Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo. Development 2003, 130:5851-5860.
22. Sitnik R., Campiotto S., Vainzof M., et al. Novel point mutations in the dystrophin gene. Hum Mutat 1997, 10:217-222.
23. Muntoni F., Torelli S., Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003, 2:731-740.
24. Guyon J.R., Goswami J., Jun S.J., et al. Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin. Hum Mol Genet 2009, 18:202-211.
25. Berger J., Berger S., Hall T.E., Lieschke G.J., Currie P.D. Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology. Neuromuscul Disord 2010, 20:826-832.
26. Miner J.H., Yurchenco P.D. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol 2004, 20:255-284.
27. Helbling-Leclerc A., Zhang X., Topaloglu H., et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995, 11:216-218.
28. Allamand V., Sunada Y., Salih M.A., et al. Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. Hum Mol Genet 1997, 6:747-752.
29. Naom I., D'Alessandro M., Sewry C.A., et al. Laminin alpha 2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy. Neuromuscul Disord 1998, 8:495-501.
30. Tan E., Topaloglu H., Sewry C., et al. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency. Neuromuscul Disord 1997, 7:85-89.
31. Hall T.E., Bryson-Richardson R.J., Berger S., et al. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy. Proc Natl Acad Sci USA 2007, 104:7092-7097.
32. Straub V., Rafael J.A., Chamberlain J.S., Campbell K.P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 1997, 139:375-385.
33. Williamson R.A., Henry M.D., Daniels K.J., et al. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 1997, 6:831-841.
34. Dincer P., Balci B., Yuva Y., et al. A novel form of recessive limb girdle muscular dystrophy with mental retardation and abnormal expression of alpha-dystroglycan. Neuromuscul Disord 2003, 13:771-778.
35. Hara Y., Balci-Hayta B., Yoshida-Moriguchi T., et al. A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med 2011, 364:939-946.
36. Beltran-Valero de Bernabe D., Currier S., Steinbrecher A., et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002, 71:1033-1043.
37. Kobayashi K., Nakahori Y., Miyake M., et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998, 394:388-392.
38. van Reeuwijk J., Janssen M., van den Elzen C., et al. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet 2005, 42:907-912.
39. Yoshida A., Kobayashi K., Manya H., et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001, 1:717-724.
40. Brockington M., Blake D.J., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 2001, 69:1198-1209.
41. Lefeber D.J., Schonberger J., Morava E., et al. Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. Am J Hum Genet 2009, 85:76-86.
42. Longman C., Brockington M., Torelli S., et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 2003, 12:2853-2861.
43. Godfrey C., Clement E., Mein R., et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007, 130:2725-2735.
44. Lin Y.Y., White R.J., Torelli S., Cirak S., Muntoni F., Stemple D.L. Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies. Hum Mol Genet 2011, 20:1763-1775.
45. Gupta V., Kawahara G., Gundry S.R., et al. The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies. Hum Mol Genet 2011, 20:1712-1725.
46. Inamori K., Yoshida-Moriguchi T., Hara Y., Anderson M.E., Yu L., Campbell K.P. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 2012, 335:93-96.
47. Barresi R., Michele D.E., Kanagawa M., et al. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med 2004, 10:696-703.
48. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993, 122:809-823.
49. Zhang Z., Zhang P., Hu H. LARGE Expression Augments the Glycosylation of Glycoproteins in Addition to alpha-Dystroglycan Conferring Laminin Binding. PLoS One 2011, 6:e19080.
50. Jacoby A.S., Busch-Nentwich E., Bryson-Richardson R.J., et al. The zebrafish dystrophic mutant softy maintains muscle fibre viability despite basement membrane rupture and muscle detachment. Development 2009, 136:3367-3376.
51. Cohn R.D., Herrmann R., Wewer U.M., Voit T. Changes of laminin beta 2 chain expression in congenital muscular dystrophy. Neuromuscul Disord 1997, 7:373-378.
52. Zenker M., Aigner T., Wendler O., et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 2004, 13:2625-2632.
53. Knoll R., Postel R., Wang J., et al. Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation 2007, 116:515-525.
54. Postel R., Vakeel P., Topczewski J., Knoll R., Bakkers J. Zebrafish integrin-linked kinase is required in skeletal muscles for strengthening the integrin-ECM adhesion complex. Dev Biol 2008, 318:92-101.
55. Hayashi Y.K., Chou F.L., Engvall E., et al. Mutations in the integrin alpha7 gene cause congenital myopathy. Nat Genet 1998, 19:94-97.
56. Arikkath J., Campbell K.P. Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol 2003, 13:298-307.
57. Meissner G. Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors. Annu Rev Physiol 1994, 56:485-508.
58. Block B.A., Imagawa T., Campbell K.P., Franzini-Armstrong C. Structural evidence for direct interaction between the molecular components of the transverse tubule/sarcoplasmic reticulum junction in skeletal muscle. J Cell Biol 1988, 107:2587-2600.
59. Hirata H., Watanabe T., Hatakeyama J., et al. Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease. Development 2007, 134:2771-2781.
60. Monnier N., Ferreiro A., Marty I., Labarre-Vila A., Mezin P., Lunardi J. A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia. Hum Mol Genet 2003, 12:1171-1178.
61. Schredelseker J., Di Biase V., Obermair G.J., et al. The beta 1a subunit is essential for the assembly of dihydropyridine-receptor arrays in skeletal muscle. Proc Natl Acad Sci USA 2005, 102:17219-17224.
62. Zhou W., Saint-Amant L., Hirata H., Cui W.W., Sprague S.M., Kuwada J.Y. Non-sense mutations in the dihydropyridine receptor beta1 gene, CACNB1, paralyze zebrafish relaxed mutants. Cell Calcium 2006, 39:227-236.
63. Schredelseker J., Dayal A., Schwerte T., Franzini-Armstrong C., Grabner M. Proper restoration of excitation-contraction coupling in the dihydropyridine receptor beta1-null zebrafish relaxed is an exclusive function of the beta1a subunit. J Biol Chem 2009, 284:1242-1251.
64. Barral J.M., Hutagalung A.H., Brinker A., Hartl F.U., Epstein H.F. Role of the myosin assembly protein UNC-45 as a molecular chaperone for myosin. Science 2002, 295:669-671.
65. Etard C., Behra M., Fischer N., Hutcheson D., Geisler R., Strahle U. The UCS factor Steif/Unc-45b interacts with the heat shock protein Hsp90a during myofibrillogenesis. Dev Biol 2007, 308:133-143.
66. Hawkins T.A., Haramis A.P., Etard C., et al. The ATPase-dependent chaperoning activity of Hsp90a regulates thick filament formation and integration during skeletal muscle myofibrillogenesis. Development 2008, 135:1147-1156.
67. Etard C., Roostalu U., Strahle U. Shuttling of the chaperones Unc45b and Hsp90a between the A band and the Z line of the myofibril. J Cell Biol 2008, 180:1163-1175.
68. Gordon A.M., Homsher E., Regnier M. Regulation of contraction in striated muscle. Physiol Rev 2000, 80:853-924.
69. Galinska-Rakoczy A., Engel P., Xu C., et al. Structural basis for the regulation of muscle contraction by troponin and tropomyosin. J Mol Biol 2008, 379:929-935.
70. Sehnert A.J., Huq A., Weinstein B.M., Walker C., Fishman M., Stainier D.Y. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet 2002, 31:106-110.
71. Ferrante M.I., Kiff R.M., Goulding D.A., Stemple D.L. Troponin T is essential for sarcomere assembly in zebrafish skeletal muscle. J Cell Sci 2011, 124:565-577.
72. Ehler E., Rothen B.M., Hammerle S.P., Komiyama M., Perriard J.C. Myofibrillogenesis in the developing chicken heart: assembly of Z-disk, M-line and the thick filaments. J Cell Sci 1999, 112(Pt 10):1529-1539.
73. Sanger J.W., Chowrashi P., Shaner N.C., et al. Myofibrillogenesis in skeletal muscle cells. Clin Orthop Relat Res 2002, S153-S162.
74. Holtzer H., Hijikata T., Lin Z.X., et al. Independent assembly of 1.6 microns long bipolar MHC filaments and I-Z-I bodies. Cell Struct Funct 1997, 22:83-93.
75. Sanger J.W., Wang J., Holloway B., Du A., Sanger J.M. Myofibrillogenesis in skeletal muscle cells in zebrafish. Cell Motil Cytoskeleton 2009, 66:556-566.
76. Robu M.E., Larson J.D., Nasevicius A., et al. P53 activation by knockdown technologies. PLoS Genet 2007, 3:e78.
77. Eisen J.S., Smith J.C. Controlling morpholino experiments: don't stop making antisense. Development 2008, 135:1735-1743.
78. Wienholds E., van Eeden F., Kosters M., Mudde J., Plasterk R.H., Cuppen E. Efficient target-selected mutagenesis in zebrafish. Genome Res 2003, 13:2700-2707.
79. Stemple D.L. TILLING-a high-throughput harvest for functional genomics. Nat Rev Genet 2004, 5:145-150.
80. Henikoff S., Till B.J., Comai L. TILLING. Traditional mutagenesis meets functional genomics. Plant Physiol 2004, 135:630-636.
81. Kettleborough R.N., Bruijn E., Eeden F., Cuppen E., Stemple D.L. High-throughput target-selected gene inactivation in zebrafish. Methods Cell Biol 2011, 104:121-127.
82. Jao L.E., Maddison L., Chen W., Burgess S.M. Using retroviruses as a mutagenesis tool to explore the zebrafish genome. Brief Funct Genomic Proteomic 2008, 7:427-443.
83. Wang D., Jao L.E., Zheng N., et al. Efficient genome-wide mutagenesis of zebrafish genes by retroviral insertions. Proc Natl Acad Sci USA 2007, 104:12428-12433.
84. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005, 4:35-44.
85. Strahle U., Grabher C. The zebrafish embryo as a model for assessing off-target drug effects. Dis Model Mech 2010, 3:689-692.
86. Behra M., Cousin X., Bertrand C., et al. Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo. Nat Neurosci 2002, 5:111-118.
87. Soreq H., Seidman S. Acetylcholinesterase-new roles for an old actor. Nat Rev Neurosci 2001, 2:294-302.
88. Behra M., Etard C., Cousin X., Strahle U. The use of zebrafish mutants to identify secondary target effects of acetylcholine esterase inhibitors. Toxicol Sci 2004, 77:325-333.
89. Kawahara G., Karpf J.A., Myers J.A., Alexander M.S., Guyon J.R., Kunkel L.M. Drug screening in a zebrafish model of Duchenne muscular dystrophy. Proc Natl Acad Sci USA 2011, 108:5331-5336.
90. Adamo C.M., Dai D.F., Percival J.M., et al. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci USA 2010, 107:19079-19083.